200 related articles for article (PubMed ID: 34375644)
41. Biochemical and Genetic Analysis of Seven Korean Individuals With Suspected Metachromatic Leukodystrophy.
Han M; Jun SH; Lee YJ; Eun BL; Lee SJ; Seong MW; Park SS; Song SH; Park HD; Song J
Ann Lab Med; 2015 Jul; 35(4):458-62. PubMed ID: 26131420
[TBL] [Abstract][Full Text] [Related]
42. Disease-causing mutations in cis with the common arylsulfatase A pseudodeficiency allele compound the difficulties in accurately identifying patients and carriers of metachromatic leukodystrophy.
Rafi MA; Coppola S; Liu SL; Rao HZ; Wenger DA
Mol Genet Metab; 2003 Jun; 79(2):83-90. PubMed ID: 12809637
[TBL] [Abstract][Full Text] [Related]
43. Quantification of plasma sulfatides by mass spectrometry: Utility for metachromatic leukodystrophy.
Saville JT; Smith NJ; Fletcher JM; Fuller M
Anal Chim Acta; 2017 Feb; 955():79-85. PubMed ID: 28088283
[TBL] [Abstract][Full Text] [Related]
44. Diagnosis of arylsulfatase A deficiency in intact cultured cells using a fluorescent derivative of cerebroside sulfate.
Bach G; Dagan A; Herz B; Gatt S
Clin Genet; 1987 Apr; 31(4):211-7. PubMed ID: 2885115
[TBL] [Abstract][Full Text] [Related]
45. Metachromatic leukodystrophy: molecular genetics and an animal model.
Gieselmann V; Matzner U; Hess B; Lüllmann-Rauch R; Coenen R; Hartmann D; D'Hooge R; DeDeyn P; Nagels G
J Inherit Metab Dis; 1998 Aug; 21(5):564-74. PubMed ID: 9728336
[TBL] [Abstract][Full Text] [Related]
46. Biochemical profiling to predict disease severity in metachromatic leukodystrophy.
Tan MA; Fuller M; Zabidi-Hussin ZA; Hopwood JJ; Meikle PJ
Mol Genet Metab; 2010 Feb; 99(2):142-8. PubMed ID: 19815439
[TBL] [Abstract][Full Text] [Related]
47. A variant form of metachromatic leukodystrophy without arylsulfatase deficiency.
Hahn AF; Gordon BA; Hinton GG; Gilbert JJ
Ann Neurol; 1982 Jul; 12(1):33-6. PubMed ID: 6126151
[TBL] [Abstract][Full Text] [Related]
48. Pseudodeficiency of arylsulfatase A: a counseling dilemma.
Baldinger S; Pierpont ME; Wenger DA
Clin Genet; 1987 Feb; 31(2):70-6. PubMed ID: 2881636
[TBL] [Abstract][Full Text] [Related]
49. Treatment of adult metachromatic leukodystrophy model mice using intrathecal administration of type 9 AAV vector encoding arylsulfatase A.
Miyake N; Miyake K; Sakai A; Yamamoto M; Suzuki H; Shimada T
Sci Rep; 2021 Oct; 11(1):20513. PubMed ID: 34654893
[TBL] [Abstract][Full Text] [Related]
50. Evolutionary redesign of the lysosomal enzyme arylsulfatase A increases efficacy of enzyme replacement therapy for metachromatic leukodystrophy.
Simonis H; Yaghootfam C; Sylvester M; Gieselmann V; Matzner U
Hum Mol Genet; 2019 Jun; 28(11):1810-1821. PubMed ID: 30657900
[TBL] [Abstract][Full Text] [Related]
51. Developing therapeutic approaches for metachromatic leukodystrophy.
Patil SA; Maegawa GH
Drug Des Devel Ther; 2013; 7():729-45. PubMed ID: 23966770
[TBL] [Abstract][Full Text] [Related]
52. Correction of brain oligodendrocytes by AAVrh.10 intracerebral gene therapy in metachromatic leukodystrophy mice.
Piguet F; Sondhi D; Piraud M; Fouquet F; Hackett NR; Ahouansou O; Vanier MT; Bieche I; Aubourg P; Crystal RG; Cartier N; Sevin C
Hum Gene Ther; 2012 Aug; 23(8):903-14. PubMed ID: 22642214
[TBL] [Abstract][Full Text] [Related]
53. Successful transduction of oligodendrocytes and restoration of arylsulfatase A deficiency in metachromatic leukodystrophy fibroblasts using an adenovirus vector.
Ohashi T; Watabe K; Sato Y; Saito I; Barranger JA; Eto Y
Gene Ther; 1995 Sep; 2(7):443-9. PubMed ID: 7584122
[TBL] [Abstract][Full Text] [Related]
54. Urine sulfatides and the diagnosis of metachromatic leukodystrophy.
Natowicz MR; Prence EM; Chaturvedi P; Newburg DS
Clin Chem; 1996 Feb; 42(2):232-8. PubMed ID: 8595716
[TBL] [Abstract][Full Text] [Related]
55. Oligodendroglial progenitor cell therapy limits central neurological deficits in mice with metachromatic leukodystrophy.
Givogri MI; Galbiati F; Fasano S; Amadio S; Perani L; Superchi D; Morana P; Del Carro U; Marchesini S; Brambilla R; Wrabetz L; Bongarzone E
J Neurosci; 2006 Mar; 26(12):3109-19. PubMed ID: 16554462
[TBL] [Abstract][Full Text] [Related]
56. Higher precision, first tier newborn screening for metachromatic leukodystrophy using 16:1-OH-sulfatide.
Bekri S; Bley A; Brown HA; Chanson C; Church HJ; Gelb MH; Hong X; Janzen N; Kasper DC; Mechtler T; Morton G; Murko S; Oliva P; Tebani A; Wu THY
Mol Genet Metab; 2024 May; 142(1):108436. PubMed ID: 38552449
[TBL] [Abstract][Full Text] [Related]
57. Elucidating the Therapeutic Utility of Olaparib in Sulfatide-Induced Human Astrocyte Toxicity and Neuroinflammation.
Mekhaeil M; Conroy MJ; Dev KK
J Neuroimmune Pharmacol; 2023 Dec; 18(4):592-609. PubMed ID: 37924373
[TBL] [Abstract][Full Text] [Related]
58. Genetic complementation in somatic cell hybrids of cerebroside sulfatase activator deficiency and metachromatic leukodystrophy fibroblasts.
Kihara H; Tsay KK; Fluharty AL
Hum Genet; 1984; 66(4):300-1. PubMed ID: 6144627
[TBL] [Abstract][Full Text] [Related]
59. Transduced fibroblasts and metachromatic leukodystrophy lymphocytes transfer arylsulfatase A to myelinating glia and deficient cells in vitro.
Sangalli A; Taveggia C; Salviati A; Wrabetz L; Bordignon C; Severini GM
Hum Gene Ther; 1998 Sep; 9(14):2111-9. PubMed ID: 9759937
[TBL] [Abstract][Full Text] [Related]
60. Probable metachromatic leukodystrophy/pseudodeficiency compound heterozygote at the arylsulfatase A locus with neurological and psychiatric symptomatology.
Hohenschutz C; Friedl W; Schlör KH; Waheed A; Conzelmann E; Sandhoff K; Propping P
Am J Med Genet; 1988 Sep; 31(1):169-75. PubMed ID: 2906225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
